We are delighted to host a Healthtech CEO Forum on April 30th, 2024 during the 10th LSX World Congress.
Panel discussion: 11:00-12:15
Our distinguished panel discussion will cover real life experiences of growing and scaling up businesses in the healthtech sector. Topics to cover include:
The panel will be moderated by Head of our life sciences practice, Susanna Stanfield, and leading life sciences attorney, Tom Meyers. Guest speakers include:
To RSVP, please get in touch with LSX here.
Whether one is considering a permanent or temporary international relocation, careful tax planning is essential. In this seminar, our speakers will be discussing recent updates and key considerations when individuals decide to move into or out of the US.
In a world where the economic climate directly influences corporate health, the processes of liquidating both listed and non-listed companies have become more pertinent than ever. These scenarios present unique challenges and opportunities for companies and investors alike.
Alongside a panel of esteemed experts from FTI Consulting and Omni Bridgeway, our legal advisors, Gary Leung and Justin Yip, will share their insights and experiences on these critical topics. Join us as we examine the practical, legal and financial considerations during these processes, including:
Liquidation insights:
Litigation funding:
The unprecedented write-down of Credit Suisse AT1 bonds affected billions of bonds globally, and Asia has felt the impact no less than anywhere else in the world. Indeed, investors from Asia-Pacific form a substantial part of the exposure.
Withers has been advising bondholders and working on the Credit Suisse AT1 crisis since the collapse of Credit Suisse, and is one of the first global law firms to represent bondholders in Asia.
The Hong Kong market has also reportedly suffered exposure from the crisis. The impact of the fallout is now being crystallized one year on, and many investors are looking for means to recover their losses against the Switzerland Confederation.
Join us as we consider the impact of the crisis and explore the options available to affected investors.
Since 2019, Japan has been the largest source of foreign direct investment into the US.
We are delighted to invite you to a seminar about M&A into the USA to be held at our Withers Tokyo office. This seminar presents a unique opportunity for Japanese corporates seeking to expand their presence in the American market, and to hear from our experts and thought leaders on existing trends as well as the legal and tax considerations when it comes to cross-border investments.
Please note that the seminar will be conducted mainly in Japanese, with English speaker presentations accompanied by Japanese translations.
We look forward to your presence at this insightful seminar.
On 6th March 2024, the UK Government made a surprise announcement that it intends to abolish the over 200 year old non-dom regime and replace it in April 2025 with a radically different regime and set of rules.
This will have far-reaching consequences, not only for those under the current regime but also in attracting investment into the UK.
To help you navigate this time of uncertainty, speakers Andrew Talbot and Michael Borchert from Avrio Wealth, and Tom McElligott from Withersworldwide, will explore crucial aspects of this pivotal shift.
In this seminar, we will cover the following topics: